Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Transgenomic Hires Two New VPs; Worland Joins GenMark Board

Premium

Transgenomic has appointed Matthew Beer as vice president of business development for oncology; and John McAuliffe as vice president of business development for neurology.

Beer was previously director of oncology marketing and hematology/oncology life cycle leader at Quest Diagnostics. Prior to that, he was vice president of business development at Caris Life Sciences. He has also worked for Abbott, Targeted Molecular Diagnostics, and Oncotech. He holds a BS in microbiology from the University of Iowa.

McAuliffe previously worked at HistoRx, where he served as vice president of sales. Prior to that, he was director of business development at Athena Diagnostics. McAuliffe holds a BS in pharmacolopgy from the University of California, Santa Barbara.


GenMark Diagnostics said this week that Stephen Worland has been appointed to its board of directors.

Worland is currently president and CEO of Effector Therapeutics. He was president and CEO and a director of Anadys Pharmaceuticals from 2007 until the company was acquired by Roche in 2011. Worland joined Anadys in 2001 and served in a number of executive roles prior to being named CEO, including president of pharmaceuticals and chief scientific officer. He began his healthcare industry career in 1988 at Agouron Pharmaceuticals.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.